Scancell presents positive data from the first stage in its Phase 2 SCOPE trial at the 20th International Congress of the Society for Melanoma Research To download click here
Scancell announces late-breaking abstract presenting positive data from the first stage in its Phase 2 SCOPE trial To download click here